Age-Related Macular Degeneration Preferred Practice Pattern®

Ophthalmology. 2020 Jan;127(1):P1-P65. doi: 10.1016/j.ophtha.2019.09.024. Epub 2019 Sep 25.

Authors

Christina J Flaxel¹, Ron A Adelman², Steven T Bailey¹, Amani Fawzi³, Jennifer I Lim⁴, G Atma Vemulakonda⁵, Gui-Shuang Ying⁶

Affiliations

¹ Casey Eye Institute, Oregon Health & Science University, Portland, OR.
² Yale University Eye Center, New Haven, CT.
³ Feinberg School of Medicine, Northwestern University, Chicago, IL.
⁴ University of Illinois at Chicago, Chicago, IL.
⁵ Department of Ophthalmology, Palo Alto Medical Foundation, Palo Alto, CA.
⁶ Center for Preventative Ophthalmology and Biostatistics, Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.

PMID: 31757502
DOI: 10.1016/j.ophtha.2019.09.024

No abstract available

Publication types

Practice Guideline

MeSH terms

Academies and Institutes / standards
Aged
Angiogenesis Inhibitors / therapeutic use
Coloring Agents / administration & dosage
Female
Fluorescein Angiography
Humans
Indocyanine Green / administration & dosage
Intravitreal Injections
Laser Coagulation
Macular Degeneration / diagnosis*
Macular Degeneration / therapy*
Male
Ophthalmology / organization & administration
Practice Patterns, Physicians' / standards*
Quality of Health Care / standards
Tomography, Optical Coherence
United States
Vascular Endothelial Growth Factor A / antagonists & inhibitors

Substances

Angiogenesis Inhibitors
Coloring Agents
VEGFA protein, human
Vascular Endothelial Growth Factor A
Indocyanine Green